A2VE02 AF NFT

Junctional protein associated with coronary artery disease homolog

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicvddxf623pjhxklg3jumkydqqs2ermt46b5p5poh2f5mclh3nonq/metadata.json
IPFS of structure file: 
bafybeicnmqg4n45ik4nmgtqdzbmnfzpx3dml2fc5c5lbpse2abknab4fmm/AF-A2VE02-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x46EfCa788d03A3e879DAcDb96552AB8Bbc7e20b3
First NFT owner address (bech32): 
genesis1gmhu57ydqw37s7w6ekuk254t3w78ug9ndfc7sx
Current NFT ID #196267 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
196267
Accession (UniProt):
A2VE02
Name::
Junctional protein associated with coronary artery disease homolog
Experimental Method:
Predicted structure
Sequence source:
BOS TAURUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A2VE02 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A2VE02|JCAD_BOVIN Junctional protein associated with coronary artery disease homolog OS=Bos taurus OX=9913 GN=JCAD PE=2 SV=1 MYSVEDLLISHGYKLSRKLPAPHEDDGERRQPARTTVPAGPGLLNGCDDGPAALPRGKASPGTGLLSDPESRRLGPRGHGERPSTAAAARISEAGFYHQPVLAWSSQPLTGRSHAYWRRREQEAREDPGGRGPVPSLPTHPREGPWEVGGRSEHVMKKAVWEDELGMAGPARWQDVSVRSWNQPPRLGRQMSDGVGEKLFQDLYPFMLGEHGLTSQSKGKSQSLPRVLSPESLSCMEVPIPLSDGHLPGVPKVPLQPPNCASNLESTRNPKKAGTSAPLPQPRFGRPLKPPSYGSQPHSKAGAENGSYTDSRQLDPGAAHSARTNSARQDLYGPDPGLEPPVYVPPPSYKSPPQPAAHPCPEEAVSRHEGRGRRVPQHPMERPAAGGQPLSGSRGAGSEWGASPCSPVGVPPQPHHTTAYDGSILIIPFDDPRIRHIKLPRPHGFWEDVKLDGAVPAPDPRSLQQEGAVWGPSGKERGPAPADPSPSWLWGQPPRNGENGSSPDQRDPCIVTQRKQPDVSGSPQEYPESLVSSPSPQGESSCEMQTQLRKFEAGLQPKRSSKKKTSETIFCLVSIPVKSESQLPGTDTNNNDLKQSASLQEQSVLSLSSTDLELQALTGSMATRTELPRPDPGGPGRGRQADDLRFPSPAKHRALAWPGPWPGHHFRDQQTQTSFAHEPQSLQPLPGERPGGSPDPVLPPRCLDPAPFEVQMHMALASSDPNQRPGAHSPKSQGSLSPSSNSAFSGSSWPRNQGPVPRASLGQQGSDGPGRRASPVSRGEVIKGETTGPCNSRQLFGQFLLKPVSRRPWDLISQLESFNKELQEEEGSSGSSSDGSGSEDSDTELPWGSCARPAPQLPGLLKDIVPEDPRTRPGRVKSKSESWSEEGRPRSPRPWQAEGRGSVWLSPPGSWIAEDGDREVEDRVAQLAVSPRPVKRAISSGLNDAKPEPPPDPAEQREPLPSQELPGSRGAVELSAAGPPRAGGGEQGSTRAPLSLAGKSRGLSAPDLRSVGLTLVQEHSTSQLAGSPGDANAIEIPPNESLEARAARILGIEVAVESLLPGAQRAGQRRHPEPDGSALRPESPRQEAAASLAQPNESTAPADAFYGRRKCGWTKSPLFVGERDSTRQVPRASEPADVDGAVPTKAPETPPSPLESQPFLPKDVETKPPFRSTLFHFIERTPNLAFSEKKLRNTSRVIESLQEKLVSPPRKADPDRLTRMKEVSSVSRMRLLTSRAADSAEEPKAERGPGAWLGGLVAPSAGHKLSDPQGALSLEADGHPAARRENGGRDFWCPDSYDPSRVERV